Leukemia Clinical Trials in Atlanta

Showing 1461-1466 of 1,466 trials

Study for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

NCT00129948

This is a phase 2, single-arm, open-label, multi-center study to establish the safety and efficacy of Troxatyl™ (troxacitabine) administered as a continuous infusion for 5 days to subjects with AML.

Leukemia, Myeloid, Acute

SGX Pharmaceuticals, Inc.211 participantsStarted Jul 2005

La Jolla, California, United States • Los Angeles, California, United States • San Diego, California, United States +17 more locations

COMPLETEDPhase 1/219 miles

Autologous T Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL) Patients

NCT00058656

Patients will have immune cells collected and then expanded outside of the body. Patients will receive an infusion of a large number of expanded immune cells. There will be three dose levels studied. The goal of the study will be to determine the safety as well as potential efficacy of this treatment.

Chronic Lymphocytic Leukemia

Xcyte Therapies18 participantsStarted Mar 2003

San Diego, California, United States • Roswell, Georgia, United States • Bethesda, Maryland, United States +1 more locations

Study for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Autologous T Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL) Patients

Leukemia Trials in Other Cities

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer.

Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung Cancer

CP-481,715 Nickel Allergy Study.

Other Conditions in Atlanta